Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
LFW Photonics Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Champions Oncolog
(NQ:
CSBR
)
4.220
+0.040 (+0.96%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Champions Oncolog
< Previous
1
2
Next >
CSBR Stock Earnings: Champions Oncology Beats EPS, Beats Revenue for Q4 2024
July 18, 2024
CSBR stock results show that Champions Oncology beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
June 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 05, 2024
Via
Benzinga
Champions Oncology: Q3 Earnings Insights
March 12, 2024
Via
Benzinga
Earnings Outlook For Champions Oncology
March 11, 2024
Via
Benzinga
Insiders Buying Solid Biosciences And 2 Other Stocks
January 16, 2024
Although U.S. stocks closed mixed on Friday, there were a few notable insider trades.
Via
Benzinga
Recap: Champions Oncology Q2 Earnings
December 12, 2023
Via
Benzinga
Earnings Outlook For Champions Oncology
September 12, 2023
Via
Benzinga
Champions Oncology Earnings Perspective: Return On Capital Employed
July 25, 2023
Via
Benzinga
Earnings Scheduled For March 12, 2024
March 12, 2024
Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.
Via
Benzinga
Insiders Buying Tilly's And 2 Other Stocks
January 10, 2024
Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades.
Via
Benzinga
Champions Oncology's Earnings: A Preview
July 21, 2023
Via
Benzinga
Champions Oncology's Earnings: A Preview
March 14, 2023
Via
Benzinga
Champions Oncology's Return On Capital Employed Insights
December 30, 2022
Via
Benzinga
Why Is RiskOn International (ROI) Stock Up 28% Today?
December 13, 2023
RiskOn International stock is rising higher on Wednesday as investors react to insider buying of ROI shares by Milton C. Ault III.
Via
InvestorPlace
CSBR Stock Earnings: Champions Oncology Beats EPS, Misses Revenue for Q2 2024
December 12, 2023
CSBR stock results show that Champions Oncology beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Earnings Scheduled For December 12, 2023
December 12, 2023
Companies Reporting Before The Bell • CSP (NASDAQ:CSPI) is likely to report earnings for its fourth quarter.
Via
Benzinga
Johnson Controls, Oracle And 3 Stocks To Watch Heading Into Tuesday
December 12, 2023
With U.S. stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Investor Optimism Improves Further Ahead Of Inflation Data; Dow Gains For Third Straight Day
December 12, 2023
The CNN Money Fear and Greed index showed further improvement in overall market sentiment, while the index remained in the "Greed" zone on Monday. U.S. stocks closed higher on Monday, with the Dow...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
$5M Bet On Pyxis Oncology? Check Out These 4 Penny Stocks Insiders Are Buying
March 22, 2023
The Dow Jones closed higher by more than 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Earnings Scheduled For March 15, 2023
March 15, 2023
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million.
Via
Benzinga
Analyzing Champions Oncology's Short Interest
December 15, 2022
Champions Oncology's (NASDAQ:CSBR) short percent of float has risen 6.9% since its last report. The company recently reported that it has 64 thousand shares sold short, which is 0.93% of all regular...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 15, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 14, 2022
Via
Benzinga
Earnings Scheduled For September 8, 2022
September 08, 2022
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report earnings for its second quarter. • Sono Group (NASDAQ:SEV) is estimated to report earnings for its second...
Via
Benzinga
Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday
September 16, 2022
Gainers
Via
Benzinga
Earnings Preview For Champions Oncology
September 07, 2022
Champions Oncology (NASDAQ:CSBR) is set to give its latest quarterly earnings report on Thursday, 2022-09-08. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Earnings Scheduled For July 21, 2022
July 21, 2022
Companies Reporting Before The Bell • SAP (NYSE:SAP) is projected to report quarterly earnings at $1.15 per share on revenue of $7.56 billion.
Via
Benzinga
A Preview Of Champions Oncology's Earnings
July 20, 2022
Champions Oncology (NASDAQ:CSBR) is set to give its latest quarterly earnings report on Thursday, 2022-07-21. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Here's How Much You Would Have Made Owning Champions Oncology Stock In The Last 5 Years
March 21, 2022
Champions Oncology (NASDAQ:CSBR) has outperformed the market over the past 5 years by 7.88% on an annualized basis. Buying $1,000 In CSBR: 5 years ago, an investor could have...
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.